Lacosamide
Also known as: Vimpat®
Use
Lacosamide is an antiepileptic medication and measuring its serum or plasma concentration aids in ensuring compliance with therapy and optimizing dosing for seizure management. Therapeutic drug monitoring may be particularly useful in cases of suspected non‑adherence, lack of efficacy, renal dysfunction, elderly patients, or concomitant use of enzyme‑inducing antiepileptic drugs ([jdos.nicholsinstitute.com](https://jdos.nicholsinstitute.com/dos/BDMC/test/930540?utm_source=openai)).
Special Instructions
Test is not available for New York patient testing; for New York patient testing, use test code 13628 ([intellitestmanager.questdiagnostics.com](https://intellitestmanager.questdiagnostics.com/home/output/267877?utm_source=openai)).
Limitations
This assay is a laboratory‑developed test validated under CLIA regulations; it has not been cleared or approved by the FDA, which may impact regulatory oversight and inter‑lab standardization ([jdos.nicholsinstitute.com](https://jdos.nicholsinstitute.com/dos/BDMC/test/930540?utm_source=openai)).
Methodology
Mass Spectrometry
Biomarkers
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
1 mL
Container
red‑top tube (no gel)
Causes for Rejection
Serum Separator Tube (SST®)
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 30 days |
Other tests from different labs that may be relevant